February's Most Popular Stories
By Arvind Sommi
In case you missed them, below you'll find our top five stories from February 2023. This month's best stories cover various topics including type 2 therapies, the latest on glucose monitoring technology, conference coverage, and more!
1. Semaglutide, Tirzepatide, CagriSema, Oh My! Emerging Treatment Options for Obesity and Type 2 Diabetes
At ATTD 2023, a panel of experts discussed the latest medications for weight loss and the treatment of obesity. The panel highlighted two FDA-approved drugs, as well as a promising combination therapy in development.
Researchers at ATTD 2023 discussed some of the latest advancements in non-invasive glucose monitoring, including two new approaches to tackling this challenge.
It’s not always easy to talk about sex, regardless of whether you have diabetes or not. If you are a person living with diabetes, here are some important things to bear in mind when you're in the bedroom.
The world’s hottest new miracle drug for type 2 diabetes, Ozempic (semaglutide), has surged in popularity among people with and without diabetes looking to lose weight, including celebrities and influencers, causing a global shortage. So, what are people with diabetes supposed to do?
The long-awaited US launch of Dexcom G7 is here! G7 improves on Dexcom’s current continuous glucose monitoring (CGM) system, the G6, with greater accuracy, smaller size, easier insertion, and more.